Pharmaceutical Processing
Supporting clinical development and manufacture
![Photo of scientist in the lab looking through microscope Photo of scientist in the lab looking through microscope](https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/pharma-processing-06.jpg?w=1920&h=1080&q=60&fm=jpg&fit=crop&dm=1574777079&s=7730f0f93ad6cdbe81ab587a89803485 1920w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/pharma-processing-06.jpg?w=1120&h=630&q=60&fm=jpg&fit=crop&dm=1574777079&s=829390596c1ae1802dea665a87883c2e 1120w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/pharma-processing-06.jpg?w=800&h=450&q=60&fm=jpg&fit=crop&dm=1574777079&s=af91672694d79f40476f522257b0cc95 800w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/pharma-processing-06.jpg?w=1600&h=900&q=45&fm=jpg&fit=crop&dm=1574777079&s=4c6db2a6d01ca81d71b0a4fe6d2bcf66 1600w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/pharma-processing-06.jpg?w=480&h=270&q=60&fm=jpg&fit=crop&dm=1574777079&s=17e542193ecda408e1cb14c8e435c195 480w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/pharma-processing-06.jpg?w=960&h=540&q=45&fm=jpg&fit=crop&dm=1574777079&s=42afb3e7e50ba7fc617d0aa77aecc519 960w)
Ageing populations, the soaring cost of drug development, and resource constraints impeding the adoption of emergent technologies are just some of the challenges facing the pharmaceutical industry today. The increasing financial burden on the healthcare system as a whole has led to a pressing need for more effective and patient-centric medication. The evolution of pharmaceutical clinical development and manufacture is vital and there are many ways CPI can work with industry to bring about change.
![A photo of CPI staff members working in a lab A photo of CPI staff members working in a lab](https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/start-up-02.jpg?w=1920&h=1080&q=60&fm=jpg&fit=crop&dm=1573819393&s=f5493c3b1c0c0a3ff0ae0e09e92ba649 1920w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/start-up-02.jpg?w=1120&h=630&q=60&fm=jpg&fit=crop&dm=1573819393&s=b76ce476ec544d8e2a9b2b691e626285 1120w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/start-up-02.jpg?w=800&h=450&q=60&fm=jpg&fit=crop&dm=1573819393&s=931671cb43df7269cf0bbab0c551400f 800w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/start-up-02.jpg?w=1600&h=900&q=45&fm=jpg&fit=crop&dm=1573819393&s=d3c8321ec3321fbecf4c5c780d3b75ff 1600w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/start-up-02.jpg?w=480&h=270&q=60&fm=jpg&fit=crop&dm=1573819393&s=1072dc849e2d8593c190bc0d10fb2a62 480w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/start-up-02.jpg?w=960&h=540&q=45&fm=jpg&fit=crop&dm=1573819393&s=09ab5ed555a7e06dffd7ca15607b9738 960w)
Here at CPI, we are able to support you with the development, optimisation and demonstration of a bespoke manufacturing process that works for the production of your pharmaceutical. Our highly experienced team offer a range of capabilities in both oral solid dose and parenteral dose pharmaceutical manufacture.
Browse Capabilities
Next-generation processing & analytics
We aim to enhance both your small and large molecule API production by utilising our developing cGMP-capable, disruptive processing solutions. Our customers are able to test and evaluate processes using a wide range of continuous, digital and autonomous manufacturing technologies enabling flexible and adaptable manufacturing solutions.
This enables you to create a bespoke process that is perfectly tailored to molecule and market needs, be it just-in-time or real-time-release manufacturing. We offer:
- Advanced process controls through digital design and integrated process analytics
- Reduced capital outlays and overall inventory costs
- Greater production efficiency
![A photo of a CPI staff member running a process in a lab A photo of a CPI staff member running a process in a lab](https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/pharam-processing-05.jpg?w=1920&h=1080&q=60&fm=jpg&fit=crop&dm=1574776888&s=13245d6977fa342be4c1e326f7f58af1 1920w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/pharam-processing-05.jpg?w=1120&h=630&q=60&fm=jpg&fit=crop&dm=1574776888&s=3452a71a3cf0f6e41dca41deb037229d 1120w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/pharam-processing-05.jpg?w=800&h=450&q=60&fm=jpg&fit=crop&dm=1574776888&s=9a8c4b1dd8ba25f9836ae86c1eb94918 800w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/pharam-processing-05.jpg?w=1600&h=900&q=45&fm=jpg&fit=crop&dm=1574776888&s=931b59b3931e4ef90f12659216f1547f 1600w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/pharam-processing-05.jpg?w=480&h=270&q=60&fm=jpg&fit=crop&dm=1574776888&s=107345f2ee55bcf91deb4233f53d1724 480w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/pharam-processing-05.jpg?w=960&h=540&q=45&fm=jpg&fit=crop&dm=1574776888&s=5ff849427d1d3ebb605920a7127e6d93 960w)
Enabling smart & continuous pharmaceutical processing
We partner with our customers to innovate pharmaceutical processing. We have developed significant capability in smart continuous wet-granulation technology including an integrated combination of process analytical technology (PAT) and statistical quality by design (QbD) methods to develop autonomous process control systems.
Linked with a digital twin, this enables rapid future process development through predictive digital design, based on real experimental data, for accurate modelling and increased development speed at reduced cost.
![](https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/phrama-processing-08.jpg?w=1920&h=1080&q=60&fm=jpg&fit=crop&dm=1574778446&s=dc79350f3c493f9fb3327c7447967286 1920w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/phrama-processing-08.jpg?w=1120&h=630&q=60&fm=jpg&fit=crop&dm=1574778446&s=c5581a26a772b7a5df0221511ac898d3 1120w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/phrama-processing-08.jpg?w=800&h=450&q=60&fm=jpg&fit=crop&dm=1574778446&s=c228ad77002d35d25e6aad57c940a3c7 800w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/phrama-processing-08.jpg?w=1600&h=900&q=45&fm=jpg&fit=crop&dm=1574778446&s=cf1696b657011533abefbef90a261b26 1600w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/phrama-processing-08.jpg?w=480&h=270&q=60&fm=jpg&fit=crop&dm=1574778446&s=3bb79c236d09b22f0c08b103587dad4b 480w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/phrama-processing-08.jpg?w=960&h=540&q=45&fm=jpg&fit=crop&dm=1574778446&s=cf5292ac8c643501472d6c330bff97b9 960w)
Nanomedicines and API Formulation
At CPI, we provide solutions to meet the evolving needs of the pharmaceutical industry.
Several novel and cutting-edge techniques, such as active encapsulation and nanoformulation, enable active drug particle delivery in a controlled time-and location-specific manner.
Our scientific expertise and nanomedicine development services integrate microfluidic and analytical technologies to provide formulation solutions to tackle clinical efficacy issues associated with right-time, right-place delivery, such as active delivery through the blood-brain barrier for neurological indications or orally-delivered proteins.
We also offer a variety of formulation services designed to improve efficacy and rapidly progress development. Services include API formulation feasibility studies and powder formulation characterisation. With established success across multiple sectors, such as FMCG and consumer care, we translate this experience to cross-sectoral formulation challenges and utilise high throughput robotics for rapid formulation screening and development.
![](https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/pharma-processing-04.jpg?w=1920&h=1080&q=60&fm=jpg&fit=crop&dm=1574776997&s=9e977886542d3b1b885f3ba86746d3dd 1920w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/pharma-processing-04.jpg?w=1120&h=630&q=60&fm=jpg&fit=crop&dm=1574776997&s=a6cfc7fae7027de8d9088922571d24e1 1120w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/pharma-processing-04.jpg?w=800&h=450&q=60&fm=jpg&fit=crop&dm=1574776997&s=1581eac8faff85fa9d75c25bcdf70dd7 800w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/pharma-processing-04.jpg?w=1600&h=900&q=45&fm=jpg&fit=crop&dm=1574776997&s=4bab04e658b880bb1b51b3fcb7d19fe4 1600w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/pharma-processing-04.jpg?w=480&h=270&q=60&fm=jpg&fit=crop&dm=1574776997&s=940afe282a4aa92c29705c31293cdc95 480w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/pharma-processing-04.jpg?w=960&h=540&q=45&fm=jpg&fit=crop&dm=1574776997&s=e418d4d897b1f3797ff3c999ebeff008 960w)
The Medicines Manufacturing Innovation Centre
![Photo of the The Medicines Manufacturing Innovation Centre Photo of the The Medicines Manufacturing Innovation Centre](https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/MMIC-building.jpg?w=100&h=100&q=60&fm=jpg&fit=crop&dm=1598516659&s=2230d35113ed1b9a33d81b75c133c469 100w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/MMIC-building.jpg?w=200&h=200&q=60&fm=jpg&fit=crop&dm=1598516659&s=1648a8cf74c8ab0989d4042e1e1498d6 200w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/MMIC-building.jpg?w=400&h=400&q=45&fm=jpg&fit=crop&dm=1598516659&s=5618e040300c99da567e8789ad521fbc 400w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/MMIC-building.jpg?w=300&h=300&q=60&fm=jpg&fit=crop&dm=1598516659&s=fe9fb70791812c2bdc27c9c75f1ae5f2 300w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/MMIC-building.jpg?w=600&h=600&q=45&fm=jpg&fit=crop&dm=1598516659&s=dda36fc3e1dab6a978f2c2c65c4b15d1 600w)
This unique state-of-the-art GMP facility offers transformative, digital-enabled solutions in pharmaceutical manufacturing. It enableses industry, academia, healthcare providers
and regulators to work collaboratively to address challenges and maximise technology opportunities within the medicines supply chain.
The centre is a collaboration between CPI, University of Strathclyde, UK Research & Innovation, Scottish Enterprise and founding industry partners, AstraZeneca and GSK.
Let’s innovate together
To find out more about how we can work together, please enter your details below.